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at www.jvascsurg.org.DISCUSSIONDr R. Clement Darling (Albany, NY ). The ﬁrst question I
would have for you, Joe, is do you have any information on those
patients with high-grade stenosis contralateral carotid stenosis as
opposed to just occlusion? Is there any differentiation between a
<50 and a >90?
Dr Joseph J. Ricotta. We are currently investigating that but
do not have the answer for presentation today. We will include it in
the manuscript.
DrHani Slim (London, United Kingdom). I’m sorry, I missed
the information, did you look at the state of the vertebral arteries?
Dr Ricotta. This is a registry database. We have information
on carotid imaging, for exampleultrasound, computed tomography,and magnetic resonance in terms of whether they are patent or
occluded and how stenosed they are, but we do not have any data
on the vertebral arteries.
Dr Christos Liapis (Athens, Greece). Can you please give us
an indication whether the contralateral occluded side was symp-
tomatic or asymptomatic and if this had any inﬂuence in the
outcome of the procedures.
Dr Ricotta. A few of the slides I showed were of the contra-
lateral patients according to their symptom status, and there was
no difference for patients without symptoms or with symptoms if
you compare carotid artery stenting (CAS) and carotid endarterec-
tomy (CEA). But if you take the CEA cohort, the symptomatic
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to 4.9% for symptomatic patients with contralateral carotid occlu-
sion compared with asymptomatic patients with contralateral oc-
clusion. And for CAS, if you are asymptomatic, you had a 1%
stroke risk versus a 3% stroke risk if you were symptomatic in the
contralateral occlusion group. But if you compare CAS with
CEA in the setting of contralateral occlusion, there was no differ-
ence regardless of symptoms.
Dr Liapis. Maybe I was not clear. I was referring to symptom-
atology from the occluded side, previous symptomatology, whether
the totally occluded side had produced any symptoms or not.
Dr Ricotta. Preprocedural symptoms.
Dr Liapis. That is correct, in the occluded side, in the totally
occluded side. If it was an asymptomatic total occlusion or a symp-
tomatic total occlusion.
Dr Ricotta. We have data to show whether patients were
symptomatic preprocedurally and whether they presented with
transient ischemic attack or stroke. I showed this in the ﬁrst table;
the CAS patients were more symptomatic preprocedure, but it was
not known whether it was from the ipsilateral or the contralateral
carotid artery.
Dr Donald Jacobs (St. Louis, Mo). Good presentation, and I
think we all believe that this was probably the softest indication for
carotid stenting as a high-risk criteria. But I have an issue with one
of your conclusions that shunting did not matter with CEA. And
the problem with that is that you do not know why they were
shunted. So not knowing the indications or the thought process
behind that, I think it is too big a step to say that shunting with
contralateral occlusion did not have an effect. If I can get your
comment on that.
Dr Ricotta. I think that is a good point. And I think that
based on the data, shunting did not matter.
We looked into the database and you cannot identify the
reason for people’s shunting. So did they shunt because they had
symptoms or did they shunt because they routinely shunt every
time they perform surgery?
All we know is that the patients that were shunted did not do
better statistically than the patients that were not shunted in the
asymptomatic and the symptomatic groups. It is impossible to
know from the database why that is. I would venture to guess
that, perhaps, similar to the study that was published last year by
the New England Study Group that showed that patients who
get shunted by people who do not routinely shunt do worse.
Routine shunters will probably get better results than those whoselectively shunt and then have to do so rather quickly after the ca-
rotid artery is cross-clamped and there are electrocardiographic
(EEG) changes, for example.
Dr Jacobs. Well, again, I think the problem with that is that if
you selectively shunt, those are the patients that are more likely to
have trouble because they have shown you some sign of having
ischemia.
Dr Marat Goldenberg (Chester, Pa). My question is a
follow-up to the previous question. Was there any information
available as to the people that did not shunt? Did they do the sur-
gery awake or did they use EEG monitoring? And if they used
EEG monitoring, what were the ﬁndings during the procedures.
Were any changes associated with periprocedural or postproce-
dural strokes?
Dr Ricotta. In the registry, approximately 5% to 7% of the pa-
tients received the procedure awake; in the rest of them the proce-
dure was performed using general anesthesia. I don’t have the
breakdown in terms of the patients that were shunteddhow
many were done awake and how many were not. For the overall
CEA groupd11,000-plus patientsd90% or more were performed
using general anesthesia.
Dr Walter Dorigo (Florence, Italy). Did you investigate in
your analysis only ipsilateral strokes or also contralateral strokes?
And if yes, did you ﬁnd a difference between occluded or nonoc-
cluded contralateral carotid artery?
Dr Ricotta. Again, there is no way to tell from the database
the territory of stroke. We just know that the patients either had
a stroke or did not have a stroke.
Dr Sateesh Babu (Hawthorne, NY). One of the clinical syn-
dromes in this particular group of patientsdthe high-grade steno-
sis ipsilateral and contralateral occlusiondis the hyperperfusion
syndrome that we are all concerned about. That is one of the rea-
sons why we would like to keep the hemodynamics as near normal
as possible and one of the reasons to shunt in my opinion. So did
you get any idea from this database whether the hyperfusion syn-
drome was seen in any one of these, because it is such a large
groupdand I hope that they did not mistake this for stroke.
Dr Ricotta. Again, these are patient records that are entered
into a database, and stroke was deﬁned as a neurologic insult >24
hours. You cannot tell from the database if the stroke was embolic,
ischemic, or from hyperperfusion, but as I am sure you are aware,
most strokes after CEA are embolic in nature. This is a limitation
of a database study. The power of the study is in the large number
of patients.
